글로벌 유방 생검 장비 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

유방 생검 장비 시장 분석

생검은 장기에서 조직을 외과적으로 제거하는 데 사용되는 시술을 말합니다. 이 시술은 염증 및 암성 질환을 포함한 질병의 존재 또는 정도를 확인하기 위해 수행됩니다. 만성 질환의 유병률은 유방 생검 장치 시장의 성장을 가속화하고 있습니다.

유방 생검 장비 시장 규모

글로벌 유방 생검 장비 시장 규모는 2023년에 26억 9천만 달러로 평가되었으며, 2031년까지 47억 8천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 연평균 성장률은 7.45%입니다.

보고 범위 및 시장 세분화       

Breast Biopsy Devices Market Definition

Biopsy devices refer to the devices that are utilized for removing a piece of a sample or a tissue of cells from the body in order to analyse in the laboratory for presence of a disease. The devices are used among radiologists, interventional cardiologists and surgeons. The use of these biopsy devices varies depending on the type of organ under consideration.

Breast Biopsy Devices Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

• Prevalence of Cancer

The increase in the prevalence of cancer across the globe acts as one of the major factors driving the growth of breast biopsy devices market.

• Preference for Minimally Invasive Surgeries

The increase in the inclination towards minimally invasive surgeries among population owing to the quick recovery and less pain accelerate the market growth.

• Funds and Grants

The surge in investments in the form of funds and grants for biomarker research further influence the market growth.

Opportunities

Furthermore, development of fully integrated biopsy devices extend profitable opportunities to the market players in the forecast period of 2024 to 2031. Also, emergence of liquid biopsy will assist in the expansion of the market.

Restraints/Challenges

On the other hand, concerns regarding the product recalls are expected to obstruct market growth. Also, risk of infections is projected to challenge the breast biopsy devices market in the forecast period of 2024-2031.

This breast biopsy devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on breast biopsy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Breast Biopsy Devices Market

Covid-19 had a positive impact on the breast biopsy devices market. The medical services such as biopsies witnessed decline in revenues in the years 2020 and 2021 due to the outbreak of COVID-19. Major medical procedures were declined during the pandemic in order to prevent the risk of spreading coronavirus. However, rise in the number of biopsies is expected in the post-COVID owing to the easing of restrictions.

Global Breast Biopsy Devices Market Scope

The biomarkers market is segmented on the basis of product, technique type, guidance technology and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Biopsy Needles
• Biopsy Tables
• Biopsy Wires
• Guidance Systems
• Others

Technique Type

• Fine Needle Aspiration Biopsy
• Core Needle Biopsy
• Biopsy Markers
• Mri-Guided Core Needle Biopsy
• Surgical Biopsy
• Wire Localization
• Sentinel Node Biopsy

Guidance Technology

• Fine Ultrasound-Guided
• Mammography-Guided Magnetic Resonance
• Ct-Guided Biopsy
• Other Image-Guided Breast Biopsy

End User

• Into Hospitals
• Ambulatory Surgical Centres
• Diagnostic Centres
• Other

Breast Biopsy Devices Market Regional Analysis

The breast biopsy devices market is analysed and market size insights and trends are provided by country, product, technique type, guidance technology and end user as referenced above.

The countries covered in the breast biopsy devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the breast biopsy devices market because of the large availability of trained medical professionals and availability of well-developed infrastructure facilities within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2024 to 2031 due to the surge in disposable income and rise in patient awareness toward disease screening in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The breast biopsy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for breast biopsy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the breast biopsy devices market. The data is available for historic period 2010-2020.

Breast Biopsy Devices Market Share

The breast biopsy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to breast biopsy devices market.

Breast Biopsy Devices Market Leaders Operating in the Market Are:

• Scion Medical Technologies LLC (US)
• STERYLAB S.r.l. (Italy)
• ARGON MEDICAL (US)
• Danaher (US)
• Cianna Medical (US)
• Benetec (Belgium)
• Cigna (US)
• United Medical Systems Inc. (US)
• Stryker (US)
• BD (US)
• Hologic Inc. (US)
• Devicor Medical Products Inc. (US)
• F. Hoffmann-La Roche Ltd (Switzerland)
• OncoCyte Corporation (US)
• Cook (US)
• Siemens (Germany)
• Medtronic (Ireland)
• SOMATEX Medical Technologies GmbH (Germany)
• Vigeosrl (Italy)
• Johnson & Johnson Services Inc. (US)
• Boston Scientific Corporation (US)
• Olympus Corporation (Japan)
• FUJIFILM Holdings Corporation (Japan)
• GENERAL ELECTRIC (US)
• Cardinal Health (US)
• B. Braun Melsungen AG (Germany)

Latest Development in Breast Biopsy Devices Market

• IZI Medical Products, LLC("IZI")는 2021년 3월에 연조직 생검을 목적으로 Quick-Core Auto Biopsy System("Quick-Core Auto")을 출시했습니다. Quick-Core Auto는 IZI의 Quick-Core 반자동 생검 시스템의 정밀성, 신뢰성 및 품질을 제공하는 가볍고 완전 자동 생검 장비로 알려져 있습니다.

SKU-1594